Goldline Pharmaceutical Limited (BOM:544759)
India flag India · Delayed Price · Currency is INR
29.60
+0.33 (1.13%)
At close: Nov 16, 2026

Goldline Pharmaceutical Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
15.555.9212.47.90.541.41
Cash & Short-Term Investments
15.555.9212.47.90.541.41
Cash Growth
--52.21%56.94%1357.38%-61.58%42.44%
Accounts Receivable
185.33161.28106.9396.2286.2786.91
Receivables
209.6161.28106.93109.84107.0586.91
Inventory
59.8462.1267.7774.9153.754.61
Other Current Assets
17.3831.1645.472.366.9434.15
Total Current Assets
302.37260.48232.57195168.23177.07
Property, Plant & Equipment
25.4426.4928.3733.6524.6720.96
Long-Term Investments
0.250.250.25-0.340.34
Other Intangible Assets
0.560.560.530.630.580.58
Long-Term Deferred Tax Assets
4.30.77----
Other Long-Term Assets
0.160.160.160.070.073.58
Total Assets
333.07288.71261.87229.35193.88202.53

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
19.818.5120.5716.448.6815.94
Accrued Expenses
-10.247.896.067.6913.18
Short-Term Debt
-59.556.557.2649.5544.22
Current Portion of Long-Term Debt
-17.4821.9213.5220.63-
Current Income Taxes Payable
-13.889.916.731.36-
Other Current Liabilities
36.021.530.861.652.071.34
Total Current Liabilities
55.81121.14117.65101.6689.9774.69
Long-Term Debt
6.6714.6331.9340.5238.1158.91
Pension & Post-Retirement Benefits
9.048.256.65.744.61-
Long-Term Deferred Tax Liabilities
--0.890.560.09-
Other Long-Term Liabilities
2.22.22.22.22.2-
Total Liabilities
73.72146.21159.27150.69134.98133.59

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
114.076923232020
Additional Paid-In Capital
-----20
Retained Earnings
145.2955.4315.5337.5820.8310.87
Comprehensive Income & Other
--46---
Total Common Equity
259.36124.4384.5360.5840.8350.87
Shareholders' Equity
259.36142.5102.678.6558.968.94
Total Liabilities & Equity
333.07288.71261.87229.35193.88202.53

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
6.6791.62110.34111.3108.29103.13
Net Cash (Debt)
8.89-85.69-97.95-103.4-107.75-101.72
Net Cash Growth
------
Net Cash Per Share
1.00-12.42-14.20-17.23-17.96-16.97
Filing Date Shares Outstanding
8.886.96.96.966
Total Common Shares Outstanding
8.886.96.96.966
Working Capital
246.56139.35114.9293.3478.26102.39
Book Value Per Share
29.2018.0312.258.786.818.48
Tangible Book Value
258.8123.878459.9540.2550.29
Tangible Book Value Per Share
29.1417.9512.178.696.718.38
Land
---4.74.7-
Buildings
-14.614.6---
Machinery
-22.4621.9220.5514.6-
Construction In Progress
---4.48--